TELA Bio Secures Lender Waiver of Revenue Covenant for Q3 and Q4 2026
TELA has more than doubled off its 52-week low of $0.501.
Summary
TELA Bio's lenders agreed to waive the minimum Revenue covenant for Q3 and Q4 2026, averting a near-term default that the company had flagged as likely in its Q2 filing.
Key Events · Financing and Capital Events · TELA
-
Revenue Covenant Waived for Two Quarters
Lenders under the November 2025 Credit Agreement agreed not to test the minimum Revenue covenant for the fiscal quarters ending September 30 and December 31, 2026.
-
Default Risk Temporarily Removed
The waiver eliminates the near-term covenant breach that TELA Bio had warned was likely in its Q2 2026 10-Q, where it disclosed substantial doubt about its ability to continue as a going concern.
-
Breathing Room for Restructuring
The consent gives management two quarters to execute its $17 million annual cost reduction plan and the proposed reverse stock split, which shareholders vote on October 8, 2026.
-
Lender Concessions Signal Distress
The need for a formal waiver confirms revenue is tracking below the original loan covenants, though lenders chose to accommodate rather than accelerate the debt.
Analysis · TELA · Industrial Applications And Services
TELA Bio's lenders have formally waived the minimum Revenue covenant for the fiscal quarters ending September 30 and December 31, 2026. This removes the immediate risk of a technical default that the company had warned about in its Q2 10-Q, buying management two quarters of breathing room while it executes its restructuring and reverse-split plan. The waiver is a survival signal, but it also confirms the company's revenue trajectory remains below the original loan terms.
How filings like this one have moved
In the 30 days to Sep 30, 2026, 29.5% of the 1626 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TELA was trading at $1.24 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $56M. The 52-week trading range was $0.50 to $1.60. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.